Kallikrein 14 anticorps
Aperçu rapide pour Kallikrein 14 anticorps (ABIN7239161)
Antigène
Voir toutes Kallikrein 14 (KLK14) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Attributs du produit
- Polyclonal Antibody
-
Purification
- Affinity purification
-
Immunogène
- Synthetic peptide of human KLK14
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:200-1:1000, IHC 1:50-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.4 mg/mL
-
Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- Kallikrein 14 (KLK14)
-
Autre désignation
- KLK14
-
Sujet
- Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. An additional transcript variant has been described but its full length nature has not been determined.
-
Poids moléculaire
- 29 kDa
-
NCBI Accession
- NP_071329
-
UniProt
- Q9P0G3
-
Pathways
- Système du Complément, Regulation of G-Protein Coupled Receptor Protein Signaling
Antigène
-